Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study
This two-center study demonstrated that high-dose pelvic radiotherapy combined with chemotherapy, including bevacizumab and ICI, may achieve favorable local control and symptom relief in patients with stage IVB CC while maintaining an acceptable safety profile.
Authors
- Kazuya Ariyoshi (ORCID: https://orcid.org/0000-0003-2467-5814)
- Naonobu Kunitake
- Kousei Ishigami (ORCID: https://orcid.org/0000-0001-8107-5570)
- Takaaki Nakashima (ORCID: https://orcid.org/0000-0001-9952-0863)
- K. Matsumoto
- Madoka Abe
- Hideaki Yahata
- Tadamasa Yoshitake
Institutions
- Kyushu University (JP)
- National Hospital Organization Kyushu Cancer Center (JP)
Publication Details
- Journal
- Japanese Journal of Radiology
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1007/s11604-025-01923-1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00